This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 1000+ CE and professional development courses.

Get access starting at $49.95/yrLoading..

Goals and Learning Outcomes

When it comes to the treatment of venous thromboembolism (VTE), every member of the healthcare team plays a critical role in ensuring patient safety. Subtherapeutic treatment can lead to blood clots, and the administration of excess dosing may lead to complications of hemorrhage. Keeping up to date with current VTE pharmacotherapy can aid in patients receiving the most optimal treatment for their condition and with providing patient education.

The goal of this course is to inform the healthcare team in the acute care setting of the most current information about VTE pharmacological treatment.


After taking this course, you should be able to:

  • Recall the American College of Chest Physicians (CHEST) guidelines, duration, and complications of medications used to treat deep vein thrombosis (DVT) and superficial vein thrombosis (SVT).
  • Recognize the classes of drugs used to treat DVT and the role of thrombolytics in the management of DVT.
  • List the adverse effects of heparin, low-molecular-weight heparin (LMWH), and vitamin K antagonists (VKAs).

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/26

Course Originally Released On: 08/01/23

Course Authors

4.5 Average

Course Reviews

8255 reviews

Accreditation Information

Nurse.com Accreditation

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.